Search
Now showing items 71-73 of 73
Lactobacillus rhamnosus GG administration partially prevents diet-induced insulin resistance in rats: a comparison with its heat-inactivated parabiotic
(RSC, 2023-09-02)
Insulin resistance and type 2 diabetes are obesity-related health alterations, featuring an ever-increasing prevalence. Besides inadequate feeding patterns, gut microbiota alterations stand out as potential contributors ...
Effects of Resveratrol Administration in Liver Injury Prevention as Induced by an Obesogenic Diet: Role of Ruminococcaceae
(MDPI, 2022-07-26)
Gut microbiota dysbiosis has been described in several metabolic disruptions, such as non-alcoholic fatty liver disease (NAFLD). Administration of resveratrol has been claimed to elicit benefits against NAFLD along with ...
Oral administration of viable or heat-inactivated Lacticaseibacillus rhamnosus GG influences on metabolic outcomes and gut microbiota in rodents fed a high-fat high-fructose diet
(Elsevier, 2023-10)
High-fat High-fructose diets have been associated with metabolic disorders and gut microbiota dysbiosis. Thus, the administration of probiotic or postbiotic from the strain Lacticaseibacillus rhamnosus GG has been investigated ...